ReviewSchizophrenia bulletin2025

Towards Enhancing Drug Development Methodology to Treat Cognitive Impairment Associated With Schizophrenia and Other Neuropsychiatric Conditions: Insights From 2 Decades of Clinical Trials.

William P Horan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.